CMC Pharmaceuticals has added current Good Manufacturing Practices (cGMP) lab services at its Solon, OH location on October 1st. This addition includes the upgrading of laboratory SOPs and documentation practices to comply with U.S. FDA guidelines. Now, data generated in CMC’s lab may be included or used to support contract customer’s filings with the U.S. FDA when cGMP lab studies are required. CMC Pharmaceuticals can now develop or improve drug product formulations, prepare prototypes of a variety of dosage forms, conduct stability and material compatibility studies, and create or optimize analytical methods that are suitable for inclusion in their clients U.S. FDA submissions.
This upgrade in capability extends CMC Pharmaceuticals ability to support their customer’s needs in drug product development services. “We started this organization five years ago to help pharma and biotech companies develop robust drug products faster,” said Mike Radomsky, Founder and President of CMC Pharmaceuticals. “This logical expansion of our service offering is in response to the expanding needs of our valued customers and allows us to directly support them with their submissions to the FDA”.
CMC Pharmaceuticals continues to operate its Mid-town Cleveland laboratory with a focus on R&D services, providing for early stage research laboratory services.
Cleveland, Ohio – October 14, 2019
CMC Pharmaceuticals announces a celebration of the five-year anniversary of its founding on October 3, 2019. CMC Pharmaceuticals hosted the celebration at its newest laboratory location. Guests were customers, suppliers and local government, including Solon (Ohio) Mayor Ed Kraus, Solon Director of Business and Marketing, Angee Shaker, Solon Councilman, Bill Russo and 14th District Congressman David Joyce’s Representative, Katie Burger. The event included a tour of CMC Pharmaceutical’s facilities to mark the important occasion.
Dr. Mike Radomsky founded CMC Pharmaceuticals in 2014, based on a mission to help pharma and biotech companies, non-profit institutions, and government agencies develop high-quality drug products more efficiently. CMC Pharmaceuticals added laboratory facilities in 2015 to provide experimentally-based, data-driven development solutions to address its customer’s drug product development and manufacturing challenges. The company has grown to two laboratory locations in the Cleveland area and increased its staff from just the original founder, to now include 10 highly experienced team members with advanced scientific backgrounds.
The majority woman-owned business now offers fully integrated formulation development, analytical development, drug product stability, and process development services from its own R&D and current good manufacturing practices (cGMP) laboratories. CMC Pharmaceuticals co-founder Casey Loveland commented, “ The Cleveland area has been a great place to grow our business, with its central location, and highly developed medical and scientific infrastructure. It has definitely contributed to the acceleration of our growth”.
“Having started a single person consulting firm that now successfully operates as a growing organization with a wide range of global customers is a great achievement for CMC Pharmaceuticals,” said Mike Radomsky, Founder and President of CMC Pharmaceuticals. “Over the last 5 years we’ve expanded our services and operations to meet our customer’s needs. We’ll assess new opportunities to continue that strategic growth moving forward.”